Duquesne Family Office's billionaire boss has gone full contrarian by selling Wall Street's two artificial intelligence (AI) darlings and piling into a previously struggling pharmaceutical stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback